Doyle, N., Varela, A., Haile, S., Guldberg, R., Kostenuik, P. J., Ominsky, M. S., . . . Hattersley, G. (2017). Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption. Osteoporos Int.
Chicago Style CitationDoyle, N., A. Varela, S. Haile, R. Guldberg, P. J. Kostenuik, M. S. Ominsky, S. Y. Smith, i G. Hattersley. "Abaloparatide, a Novel PTH Receptor Agonist, Increased Bone Mass and Strength in Ovariectomized Cynomolgus Monkeys By Increasing Bone Formation Without Increasing Bone Resorption." Osteoporos Int 2017.
Cita MLADoyle, N., et al. "Abaloparatide, a Novel PTH Receptor Agonist, Increased Bone Mass and Strength in Ovariectomized Cynomolgus Monkeys By Increasing Bone Formation Without Increasing Bone Resorption." Osteoporos Int 2017.